This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Codex Dna, Inc., Etonbio, Inc., Telesis Bio Inc. (Formerly Known as Codex Dna, Inc.). Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 3 
1 out of 3 Years Active: 2021-2025
Title: Innovations of John I Glass
Introduction
John I Glass is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of synthetic genomics, holding 2 patents that showcase his innovative work. His research focuses on the generation of synthetic genomes, which has the potential to revolutionize various applications in biotechnology.
Latest Patents
John I Glass's latest patents include methods for generating synthetic genomes. These methods allow for the creation of synthetic genomes with desired properties or viable genomes of reduced size. The patents also disclose synthetic genomes produced by these methods and synthetic cells that contain the synthetic genomes. This groundbreaking work is paving the way for advancements in genetic engineering and synthetic biology.
Career Highlights
Throughout his career, John I Glass has been associated with Codex DNA, Inc., a company that specializes in DNA synthesis and genomic technologies. His work at Codex DNA has allowed him to push the boundaries of what is possible in synthetic genomics, contributing to the development of innovative solutions in the field.
Collaborations
John I Glass has collaborated with notable scientists such as Clyde A Hutchison and Ray-Yuan Chuang. These collaborations have further enhanced his research and have led to significant advancements in the understanding and application of synthetic genomes.
Conclusion
John I Glass is a key figure in the field of synthetic genomics, with a focus on innovative methods for generating synthetic genomes. His contributions through patents and collaborations are shaping the future of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile